Richard S. Blumberg

Scientific Founder at Syntimmune, Inc.

Richard S. Blumberg

Richard S. Blumberg

Scientific Founder at Syntimmune, Inc.

Overview
Career Highlights

Syntimmune, Inc.

RelSci Relationships

2405

Number of Boards

4

Relationships
RelSci Relationships are individuals Richard S. Blumberg likely has professional access to. A relationship does not necessarily indicate a personal connection.

President, Chief Executive Officer & Director at Arch Oncology, Inc.

Relationship likelihood: Strong

Chief, Division of Gastroenterology, Hepatology & Nutrition at The Children's Hospital Corp.

Relationship likelihood: Strong

Chief Executive Officer at Abcuro, Inc.

Relationship likelihood: Strong

Chief Executive Officer at MorphoSys AG

Relationship likelihood: Strong

Director at Syntimmune, Inc.

Relationship likelihood: Strong

Director at Syntimmune, Inc.

Relationship likelihood: Strong

Former Vice President-Research & Development at Bioverativ Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Apple Tree Partners

Relationship likelihood: Strong

Provost at Harvard University

Relationship likelihood: Strong

Co-Founder at Verve Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Richard S. Blumberg
Potential Connections via
Relationship Science
You
Richard S. Blumberg
Scientific Founder at Syntimmune, Inc.
Education

Carnegie Mellon University challenges the curious and passionate to imagine and deliver work that matters. A private, global research university, Carnegie Mellon stands among the world's most renowned educational institutions, and sets its own course.With cutting-edge brain science, path-breaking performances, innovative start-ups, driverless cars, big data, big ambitions, Nobel and Turing prizes, hands-on learning, and a whole lot of robots, CMU doesn't imagine the future, they create it.

Doctorate Degree

IMPROVE LIVES AND PROVIDE STUDENTS WITH EXCEPTIONAL VALUE IN 21ST CENTURY PROFESSIONAL EDUCATION.

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

MBA

The Northeastern University D'Amore-McKim School of Business was founded in 1922 and the Graduate School of Business Administration in 1952. The D'Amore-McKim School of Business is accredited by AACSB International-The Association to Advance Collegiate Schools of Business. The Co-op M.B.A. program matriculates a class of about 80 students each fall and spring. A typical entering class includes students from fifteen or more countries other than the United States. Career goals can be equally diverse. About 90 percent have work experience, and 65 percent have earned their undergraduate degrees in areas other than business.

Memberships
Member
Current

American Society for Clinical Investigation is a private company headquartered in Ann Arbor, MI. The firm provides clinical investigation services.

Member
Current

Association of American Physicians is an American nonprofit company located in Tucson, AZ. The firm operates American association of physicians. It was founded by Charles Lee.The company says this about itself: The Association of American Physicians and Surgeons (AAPS) is a national organization representing physicians in all specialties, founded in 1943. Its motto is \"omnia pro aegroto,\" or \"all for the patient.\"

Career History
Scientific Founder
2013 - Current

Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.

Professor
Current

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Senior Chief, Gastroenterology Division
Current

Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare, an integrated health care delivery network. BWH is the home of the Carl J. and Ruth Shapiro Cardiovascular Center, the most advanced center of its kind. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving more than 900 physician-investigators and renowned biomedical scientists and faculty supported by more than $537 million in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative.

Boards & Committees
Member, National Commission on Digestive Diseases
Prior

NIH is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions in every state across America and around the globe. NIH is made up of 27 Institutes and Centers, each with a specific research agenda, often focusing on particular diseases or body systems. NIH leadership plays an active role in shaping the agency's research planning, activities, and outlook. The Office of the Director is the central office at NIH, responsible for setting policy for NIH and for planning, managing, and coordinating the programs and activities of all the NIH components. The NIH Director, with a unique and critical perspective on the entire agency, is responsible for providing leadership to the Institutes and for constantly identifying needs and opportunities, especially for efforts that involve multiple Institutes. The NIH Director is assisted by the NIH Deputy Directors including the Principal Deputy Director, who shares in the overall direction of the agency's activities. NIH is responsive to Congressional legislation that adjusts NIH's programs to meet changing research needs. As a result of the NIH reauthorization process, NIH is able to respond strategically in an era when medical research requires constant innovation and increased interdisciplinary efforts. More than 80% of the NIH's budget goes to more than 300,000 research personnel at over 2,500 universities and research institutions. In addition, about 6,000 scientists work in NIH’s own Intramural Research laboratories, most of which are on the NIH main campus in Bethesda, Maryland. The main campus is also home to the NIH Clinical Center, the largest hospital in the world totally dedicated to clinical research. Successful biomedical research depends on the talent and dedication of the scientific workforce. NIH supports many innovative training programs and funding mechanisms that foster scientific creativity and exploration. The goal is to strengthen our nation’s research capacity, broaden our research base, and inspire a passion for science in current and future generations of researchers. NIH encourages and depends on public involvement in federally supported research and activities. NIH’s wide-ranging public efforts include outreach and education, nationwide events, requests for public input on NIH projects, and special programs designed specifically to involve public representatives in clinical research

Political Donations
$500
2003

Former Senator from Connecticut

Investments
Details Hidden

Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.

Details Hidden

Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard S. Blumberg. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard S. Blumberg's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard S. Blumberg.